N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.226 NOK 2.68% Market Closed
Market Cap: 726.9m NOK
Have any thoughts about
Nykode Therapeutics ASA?
Write Note

Nykode Therapeutics ASA
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nykode Therapeutics ASA
Operating Expenses Peer Comparison

Comparables:
HBC
B
BGBIO
L
LYTIX
AZT
T
TRMED

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
N
Nykode Therapeutics ASA
OSE:NYKD
Operating Expenses
-$65m
CAGR 3-Years
-14%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Operating Expenses
-kr184m
CAGR 3-Years
-11%
CAGR 5-Years
-15%
CAGR 10-Years
-9%
B
Bergenbio ASA
OSE:BGBIO
Operating Expenses
-kr162.7m
CAGR 3-Years
20%
CAGR 5-Years
4%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Operating Expenses
-kr100.8m
CAGR 3-Years
-33%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Operating Expenses
-kr101.6m
CAGR 3-Years
-19%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
T
Thor Medical ASA
OSE:TRMED
Operating Expenses
-kr20.3m
CAGR 3-Years
63%
CAGR 5-Years
44%
CAGR 10-Years
7%

See Also

What is Nykode Therapeutics ASA's Operating Expenses?
Operating Expenses
-65m USD

Based on the financial report for Jun 30, 2024, Nykode Therapeutics ASA's Operating Expenses amounts to -65m USD.

What is Nykode Therapeutics ASA's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-67%

Over the last year, the Operating Expenses growth was 10%. The average annual Operating Expenses growth rates for Nykode Therapeutics ASA have been -14% over the past three years , -67% over the past five years .

Back to Top